Skip to main content
Premium Trial:

Request an Annual Quote

Joseph Vallner, Tom Mino, Tom Humphreys, Essam Sheta

Premium

Lumera has appointed Joseph Vallner to its board of directors. Vallner is president and chief operating officer of Cell Genesys. Prior to joining Cell Genesys in 1999, he held positions at SEQUUS Pharmaceuticals, Syntex, and G.D. Searle. Vallner was also an associate professor of pharmaceutics at the University of Georgia.

Tom Mino, president and CEO of Lumera, said in a statement that Vallner's "operational expertise in bioscience will help us to increase productivity as we grow our proteomics business."


Tom Humphreys, professor of cell and molecular biology at the John A. Burns School of Medicine at the University of Hawaii at Manoa, has been tapped to lead research initiatives for the university's new Center for Genomics, Proteomics and Bioinformatics.

Humphreys has been on the faculty at Manoa for 34 years. During that time, he organized the first recombinant DNA lab in Hawaii, led a reorganization of the UH Cancer Research Center of Hawaii, established the graduate program in cell and molecular biology and founded Hawaii Biotech, the state's biotech venture. He has accepted a three-year appointment as director of the center, effective July 1.


Essam Sheta, director of biochemistry at Power3 Medical Products, has been named to the American Institute of Biological Sciences' review panel for grant proposals related to Parkinson's disease.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.